The aim of this study is to evaluate the functional outcomes and quality of life (QoL) in oncologic patients with intraoral defects reconstructed with the buccinator myomucosal flap. A retrospective study was performed involving 39 patients with intraoral soft-tissue defects, reconstructed with a buccinator myomucosal flap during a six-year period. Patients completed the European Organization for Research and Treatment of Cancer questionnaires, the standard questionnaire (QLQ-C30) and the head-and-neck specific module (QLQ-H&N35). Thirty-nine patients with a mean age of 61.23 ± 15.80 years were included in the study. Thirty-three patients were diagnosed with an oncological condition (84.61%). Six patients (15.38%) developed orosinusal communication and underwent extensive debridement. The median global-health-status score was 79.27 and emotional performance was the lowest scoring, with a mean score of 76.93. As for the symptom items, the most outstanding were dental problems (33.33), oral opening (31.62) and dry mouth (37.61), followed by sticky saliva (24.79), problems with social eating (21.15) and pain (19.87). The most significant symptoms were radiotherapy-related adverse effects such as pain, fatigue, dental problems and dry mouth. Patients reconstructed with the buccinator myomucosal flap develop a good quality of life for all types of activities, and a correct function and aesthetics. Postoperative radiotherapy is associated with a poorer quality of life, and can lead to impairment of several symptoms such as swallowing, oral opening and dry mouth.
increase the rate of middle ear problems. 1 It does not interfere with midface advancement operations, it can be surgically adjusted if necessary to tighten or loosen the sphincter, it can be performed after a failed pharyngeal flap, and it can be used for patients with VPI and no history of cleft palate. 1 It is for the reasons that the sphincter pharyngoplasty has become a durable and popular technique for the treatment of VPI. PERSONAL EXPERIENCE AND REFLECTIONOf course, the experienced cleft surgeon is guided by the trials and tribulations of daily practice. It is this experience that we will be referring to at this time. It has been suggested in the past that patients with velocardiofacial syndrome have such profound VPI that a ''wide sub-obstructing pharyngeal flap'' was necessary for correction (Robert Shprintzen reference needed). The need for a wide sub-obstructing flap stems from the poor, or even paradoxical, lateral wall movement on attempted velopharyngeal closure. It stands to reason that a ''wide sub-obstructive'' pharyngeal flap increases the risk of obstructive sleep apnea (OSA). For this reason, the senior author has avoided such pharyngeal flaps in this cohort of patients in favor of the sphincter pharyngoplasty which has been reported to have a lower risk of OSA. The port should be designed to measure 6 mm in diameter. Overlapping the palatopharyngeal flaps so each reaches the opposite sides is favored. The risk of bleeding, particularly in patients with velocardiofacial syndrome, is of concern. MRA has been recommended in patients with locardiofacial syndrome to rule out medial displacement of the internal carotid artery. We also recommend palpating the pharynx before injecting local anesthetic.As plastic surgeons, we find the neurotized and dynamic sphincter pharyngoplasty to be supremely satisfying compared to a static adynamic pharyngeal flap. The lower risk of OSA and snoring has been reported (reference), and corresponds with our own clinical experience. A further advantage is that in our cleft patients who require maxillary advancement, pharyngeal flaps may restrict Sagittarius advancement as a consequence of the central scarring, whereas the sphincter pharyngoplasty can be left in place. Although a patient with a sphincter pharyngoplasty in place who then requires a nasotracheal intubation, will typically need an endoscopic intubation.
Sarcoma de Kaposi iatrogénico diseminado con debut en encía maxilar: a propósito de un caso. / Disseminated iatrogenic Kaposi's sarcoma with debut in the maxillary gingiva: a case report.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.